Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Alvotech (ALVO)

  • Business News
  • Nov. 02, 2025, 22:10 UTC
  • 22
  • 1 comments

Alvotech birtir nýjar upplýsingar um stöðu umsóknar um markaðsleyfi fyrir AVT05 í Bandaríkjunum

Market reaction Comment Full text

Alvotech (ALVO)

  • Business News
  • Nov. 02, 2025, 22:10 UTC
  • 21
  • 1 comments

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05

Market reaction Comment Full text

Caribou Biosciences Inc (CRBU)

  • Business News
  • Nov. 02, 2025, 21:00 UTC
  • 22
  • 1 comments

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 02, 2025, 19:34 UTC
  • 25
  • 1 comments

Stelo Glucose Biosensor System: Latest Info and Troubleshooting

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 02, 2025, 19:31 UTC
  • 25
  • 1 comments

How to Repost on Instagram

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 02, 2025, 19:27 UTC
  • 21
  • 1 comments

Best Assassin’s Creed Game: The Ultimate Guide (2025)

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 02, 2025, 19:25 UTC
  • 20
  • 1 comments

Cobra Kai: The Latest News and Updates

Market reaction Comment Full text

Northwest Biotherapeutics, Inc. (NWBO)

  • Business News
  • Nov. 02, 2025, 19:25 UTC
  • 20
  • 1 comments

Cobra Kai: The Latest News and Updates

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Nov. 02, 2025, 19:23 UTC
  • 19
  • 1 comments

Latest About iPhone 15 USB-C Connector

Market reaction Comment Full text

DexCom Inc (DXCM)

  • Business News
  • Nov. 02, 2025, 15:33 UTC
  • 18
  • 1 comments

DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM) - Contact Kessler Topaz Meltzer & Check, LLP

Market reaction Comment Full text
  • Previous
  • 924
  • 925
  • 926
  • 927
  • 928
  • Next

Search

News categories

  • Technical Exchange News(11014)
  • Event(2495)
  • SEC News(195076)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126816)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin